Prostate Cancer News and Research

Latest Prostate Cancer News and Research

PSA screening of asymptomatic men reduced risk of metastatic prostate cancer by 35 per cent

Early screening of prostate cancer in asymptomatic men may reduce their risk of death from metastatic prostate cancer by as much as 35 per cent, researchers from the University of Toronto have found.

11 Jul 2005

Northerners in the UK more prone to certain cancers

According to the office for National Statistics (ONS) ' "Cancer Atlases" for the 1990s, people in the north of England and Scotland are far more likely to get certain cancers than those living in the south.

11 Jul 2005

True validity of prostate cancer tests questioned

According to the American cancer society, more than 232,000 men will be diagnosed with prostate cancer this year, and about 30,000 will die of it.

11 Jul 2005

Accuracy of PSA screening for detecting prostate cancer

A new study indicates there is no specific PSA value that has both high sensitivity and high specificity for monitoring healthy men for prostate cancer, but rather there is a continuum of prostate cancer risk at all values of PSA, according to a study in the July 6 issue of JAMA: The Journal of the American Medical Association.

6 Jul 2005

Anti-cancer claims for green tea 'unlikely', says FDA

In what will come as a surprise, and a disappointment to many advcates, the U.S. Food and Drug Administration (FDA) said last week that drinking green tea is highly unlikely to help prevent breast, prostate or any other type of cancer.

5 Jul 2005

Kidney disease associated with 'benign' prostate obstruction

Men who experience signs and symptoms of a prostate obstruction resulting from benign prostatic hyperplasia (BPH) are three times more likely than other men to develop chronic kidney disease, according to findings of a Mayo Clinic study published in this month's edition of Kidney International.

29 Jun 2005

Don't sunbathe to avoid prostate cancer, take a pill instead

According to a recent study spending long periods in the sun may significantly reduce a man's risk of prostate cancer.

28 Jun 2005

Inactive gene may explain higher incidence of prostate cancer in African-Americans compared to Caucasians

Among African-Americans with prostate cancer, a tumor-suppressing gene called GSTP1 is inactivated at a rate 3.5 times higher than among Caucasians, according to a study conducted at the San Francisco VA Medical Center (SFVAMC).

16 Jun 2005

High exposure to the sun halves risk of prostate cancer

Cancer researchers in the U.S. say that high exposure to the sun halved the risk of prostate cancer in men participating in a U.S. trial.

16 Jun 2005

Wonder drug attacks range of cancers

A team of cancer research scientists from the Royal Marsden Hospital in London say the drug 17AAG has shown in early trials, promising signs of fighting a range of cancers.

16 Jun 2005

Exposure to sunlight may decrease the risk of prostate cancer

In the largest such study to date, a research team from three cancer centers measured sunlight exposure in men and found that increased exposure to sunlight may decrease the risk of prostate cancer.

15 Jun 2005

For men diagnosed with prostate cancer, there is no risk of recurrence if external beam radiation therapy (EBRT) is delayed by several months

A study published in the July 15, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society, finds delays of EBRT had no harmful impact on clinical outcome or biochemical marker levels in low-, intermediate- and high-risk patients.

13 Jun 2005

Diabetic men at risk of sexual dysfunction

A new study has found that diabetic men over 45 years of age are more than twice as likely as non-diabetic men to have low testosterone, putting them more at risk of sexual dysfunction.

12 Jun 2005

Finding could provide targets for diagnosis, prognosis, therapy of prostate cancer

Researchers led by Dr. Shiv Srivastava from the Center for Prostate Disease Research (CPDR), Uniformed Services University of the Health Sciences (USU), report the groundbreaking discovery of the ETS-Related Gene (ERG) as one of the frequent proto-oncogene overexpressions in prostate cancer cells.

10 Jun 2005

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.

9 Jun 2005

Toxic chemicals that poisoned your great-grandparents may also damage your health

New U.S. research is suggesting that chemicals can change the way genes work and that toxic chemicals that poisoned your great-grandparents may also damage your health.

5 Jun 2005

Scientists bridge major gap in prostate cancer research

Everyman scientists at The Institute of Cancer Research have established an initiative to promote vital research for the development and clinical testing of new drugs for the treatment of prostate cancer. This announcement coincides with the launch of The Institute's Everyman Male Cancer Awareness Month which runs throughout June.

1 Jun 2005

Shorter course of 8 gray radiotherapy effective for palliation of painful bone metastases

A single treatment of 8 gray (Gy--a unit of measure of absorbed radiation dose) of radiation appears to be as effective in palliating painful bone metastases as the current U.S. standard treatment course of 30 Gy delivered in 10 daily treatments, according to a new study in the June 1 issue of the Journal of the National Cancer Institute.

31 May 2005

Exposure to pharmaceutical estrogen during fetal development can permanently "reprogram" tissue in a way that determines whether tumors will develop in adulthood

Researchers at The University of Texas M. D. Anderson Cancer Center may have uncovered the reason why some people who are genetically predisposed to hormone-dependent cancers develop the disease as an adult, while others who are similarly susceptible don't.

30 May 2005

Bioniche Life Sciences granted European patent

Bioniche Life Sciences has announced that it has had another patent granted on its core technology: Mycobacterial Cell Wall-DNA Complex (MCC). The European Patent Organization (EPO) granted the patent: - "Composition and Method for Inducing Apoptosis in Prostate Cancer Cells" (EPO1165106)

30 May 2005